State Drug Administration issues "Implementation Opinions on 'Artificial Intelligence + Drug Regulation'".

The State Drug Administration issued the "Implementation Opinions on" Artificial Intelligence + Drug Regulation ". The "Opinions" propose that by 2030, a basic innovation system integrating drug regulation and artificial intelligence will be established. The operating management mechanism of "Artificial Intelligence + Drug Regulation" will be basically formed. The computing power support base will be more intensive and efficient, forming a high-quality data set, vertical large models, and intelligent bodies that meet the needs of intelligent regulation. Artificial intelligence will be effectively applied in scenarios such as review and approval, supervision and inspection, inspection and monitoring, and government services. Human-machine synergy efficiency will be significantly improved, and the digitalized regulation capability throughout the entire lifecycle will take a new step. By 2035, a new pattern of smart drug safety governance with digital drive, intelligent agility, self-control, and ecological collaboration will be basically formed.